A Radiobrominated Tyrosine Kinase Inhibitor for EGFR with L858R/T790M Mutations in Lung Carcinoma

Activating double mutations L858R/T790M in the epidermal growth factor receptor (EGFR) region are often observed as the cause of resistance to tyrosine kinase inhibitors (TKIs). Third-generation EGFR-TKIs, such as osimertinib and rociletinib (CO-1686), was developed to target such resistance mutatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Fawwaz, Muammar, Mishiro, Kenji, Nishii, Ryuichi, Makino, Akira, Kiyono, Yasushi, Shiba, Kazuhiro, Kinuya, Seigo, Ogawa, Kazuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998589/
https://www.ncbi.nlm.nih.gov/pubmed/33809064
http://dx.doi.org/10.3390/ph14030256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998589/
https://www.ncbi.nlm.nih.gov/pubmed/33809064
http://dx.doi.org/10.3390/ph14030256

Ejemplares similares